Literature DB >> 22116648

Live birth with vitrified-warmed oocytes of a chronic myeloid leukemia patient nine years after allogenic bone marrow transplantation.

Mi Kyoung Kim1, Dong Ryul Lee, Ji Eun Han, You Shin Kim, Woo Sik Lee, Hyung Jae Won, Ji Won Kim, Tae Ki Yoon.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22116648      PMCID： PMC3241840          DOI： 10.1007/s10815-011-9681-y

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN： 1058-0468            Impact factor:   3.412


× No keyword cloud information.
  25 in total

1.  Pregnancy and delivery of healthy infants developed from vitrified oocytes in a stimulated in vitro fertilization-embryo transfer program.

Authors:  T K Yoon; H M Chung; J M Lim; S Y Han; J J Ko; K Y Cha
Journal:  Fertil Steril       Date:  2000-07       Impact factor: 7.329

Review 2.  Impact of cancer treatment on uterine function.

Authors:  Hilary O D Critchley; W Hamish B Wallace
Journal:  J Natl Cancer Inst Monogr       Date:  2005

3.  Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients.

Authors:  Dror Meirow; Izhar Hardan; Jehoshua Dor; Eduard Fridman; Shai Elizur; Hila Ra'anani; Elena Slyusarevsky; Ninette Amariglio; Eyal Schiff; Gideon Rechavi; Arnon Nagler; Dina Ben Yehuda
Journal:  Hum Reprod       Date:  2008-03-15       Impact factor: 6.918

4.  Children born after autotransplantation of cryopreserved ovarian tissue. a review of 13 live births.

Authors:  Jacques Donnez; Sherman Silber; Claus Yding Andersen; Isabelle Demeestere; Pascal Piver; Dror Meirow; Antonio Pellicer; Marie-Madeleine Dolmans
Journal:  Ann Med       Date:  2011-01-13       Impact factor: 4.709

Review 5.  Successful pregnancy following very high-dose total body irradiation (1575 cGy) and bone marrow transplantation in a woman with acute myeloid leukemia.

Authors:  W S Wang; C H Tzeng; R K Hsieh; T J Chiou; J H Liu; C C Yen; P M Chen
Journal:  Bone Marrow Transplant       Date:  1998-02       Impact factor: 5.483

6.  American Society of Clinical Oncology recommendations on fertility preservation in cancer patients.

Authors:  Stephanie J Lee; Leslie R Schover; Ann H Partridge; Pasquale Patrizio; W Hamish Wallace; Karen Hagerty; Lindsay N Beck; Lawrence V Brennan; Kutluk Oktay
Journal:  J Clin Oncol       Date:  2006-05-01       Impact factor: 44.544

7.  Successful pregnancy in a woman with acute myeloid leukemia treated with high-dose whole-body irradiation.

Authors:  H T Chao; P H Wang; C C Yuan; W L Lee
Journal:  J Reprod Med       Date:  1998-08       Impact factor: 0.142

8.  Live births after vitrification of oocytes in a stimulated in vitro fertilization-embryo transfer program.

Authors:  Tae Ki Yoon; Thomas J Kim; Sung Eun Park; Seung Wook Hong; Jung Jae Ko; Hyung Min Chung; Kwang Yul Cha
Journal:  Fertil Steril       Date:  2003-06       Impact factor: 7.329

9.  Live birth after the transfer of human embryos developed from cryopreserved oocytes harvested before cancer treatment.

Authors:  Dunsong Yang; Samuel E Brown; Kevin Nguyen; Vijay Reddy; Cindy Brubaker; Kevin L Winslow
Journal:  Fertil Steril       Date:  2007-04-06       Impact factor: 7.329

10.  Oocyte cryopreservation in oncological patients.

Authors:  Eleonora Porcu; Raffaella Fabbri; Giuseppe Damiano; Rosita Fratto; Susanna Giunchi; Stefano Venturoli
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2004-04-05       Impact factor: 2.435
View more
  10 in total

1.  First French live-birth after oocyte vitrification performed before chemotherapy for fertility preservation.

Authors:  J Perrin; J Saïas-Magnan; F Broussais; R Bouabdallah; C D'Ercole; B Courbiere
Journal:  J Assist Reprod Genet       Date:  2016-02-09       Impact factor: 3.412

Review 2.  The role of stem cell transplantation for chronic myelogenous leukemia in the 21st century.

Authors:  A John Barrett; Sawa Ito
Journal:  Blood       Date:  2015-04-07       Impact factor: 22.113

Review 3.  Vitrification of embryos and oocytes for fertility preservation in cancer patients.

Authors:  Keiichi Kato
Journal:  Reprod Med Biol       Date:  2016-02-29

4.  Effect of different rehydration temperatures on the survival of human vitrified-warmed oocytes.

Authors:  Gao Shanshan; Li Mei; Wu Keliang; Sheng Yan; Tang Rong; Chen Zi-Jiang
Journal:  J Assist Reprod Genet       Date:  2015-05-10       Impact factor: 3.412

Review 5.  Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update.

Authors:  Alison W Loren; Pamela B Mangu; Lindsay Nohr Beck; Lawrence Brennan; Anthony J Magdalinski; Ann H Partridge; Gwendolyn Quinn; W Hamish Wallace; Kutluk Oktay
Journal:  J Clin Oncol       Date:  2013-05-28       Impact factor: 44.544

Review 6.  Fertility preservation in women with cancer.

Authors:  Michel De Vos; Johan Smitz; Teresa K Woodruff
Journal:  Lancet       Date:  2014-10-04       Impact factor: 79.321

Review 7.  Fertility preservation in women.

Authors:  Jacques Donnez; Marie-Madeleine Dolmans
Journal:  Nat Rev Endocrinol       Date:  2013-10-29       Impact factor: 43.330

8.  Editorial: Fertility Preservation in Asia.

Authors:  Jung Ryeol Lee; Seido Takae; Nao Suzuki
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-08       Impact factor: 5.555

9.  A live birth from vitrified-warmed oocytes in a Philadelphia chromosome-positive acute lymphoid leukemia patient 5 years following allogenic bone marrow transplantation and after a magnitude 9.0 earthquake in Japan.

Authors:  Masakazu Doshida; Yukiko Nakajo; Mayumi Toya; Koichi Kyono
Journal:  Reprod Med Biol       Date:  2013-06-05

10.  Successful Pregnancies, Births, and Children Development Following Oocyte Cryostorage in Female Cancer Patients During 25 Years of Fertility Preservation.

Authors:  Eleonora Porcu; Linda Cipriani; Maria Dirodi; Pierandrea De Iaco; Anna Myriam Perrone; Pier Luigi Zinzani; Mario Taffurelli; Claudio Zamagni; Patrizia Maria Ciotti; Leonardo Notarangelo; Nilla Calza; Giuseppe Damiano
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.